Skip to main content

Interruption of Bile Acid Recirculation

  • Living reference work entry
  • First Online:
Drug Discovery and Evaluation: Pharmacological Assays

Abstract

Cholesterol is metabolized in the liver by oxidation to bile acids which undergo enterohepatic circulation. In the untreated state, approximately 95 % of the bile acids that are secreted are reabsorbed and returned to the liver, while the small loss is replaced by de novo biosynthesis from cholesterol. Increased excretion of bile acids with the feces increases the rate of oxidation of cholesterol in the liver leading to a partial depletion of the hepatic cholesterol pool. A compensatory increase in uptake via the LDL receptors results in lower serum LDL levels. This can be achieved by addition of a bile acid-binding resin, e.g., cholestyramine, to the food. The binding of unconjugated and conjugated bile-salt anions can be tested in vitro (Johns and Bates 1969).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

Cholestyramine Binding

  • Ast M, Frishman WH (1990) Bile acid sequestrants. J Clin Pharmacol 30:99–106

    Article  CAS  PubMed  Google Scholar 

  • Curtius HC, Bürgi W (1966) Gaschromatographische Bestimmung des Serumcholesterins. Z Klin Chem Klin Biochem 4:38–42

    CAS  PubMed  Google Scholar 

  • Day CE (1990) Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and cholestipol hydrochloride in cholesterol fed sea quail. Artery 17:281–288

    CAS  PubMed  Google Scholar 

  • Fears R, Brown R, Ferres H, Grenier F, Tyrell AWR (1990) Effects of novel bile salts on cholesterol metabolism in rats and guinea-pigs. Biochem Pharmacol 40:2029–2037

    Article  CAS  PubMed  Google Scholar 

  • Johns W, Bates T (1969) Quantification of the binding tendencies of cholestyramine I: effect of structure and added electrolytes on the binding of unconjugated and conjugated bile salt anions. J Pharm Sci 58:179–183

    Article  CAS  PubMed  Google Scholar 

  • Kihara K, Toda H, Mori M, Hashimoto M, Mizogami S (1988) The bile acid binding and hypocholesterolemic activity of anion-exchange resins bearing the imidazolium salt group. Eur J Med Chem 23:411–415

    Article  CAS  Google Scholar 

  • Tennent DM, Siegel H, Zanetti ME, Kuron GW, Ott WH, Wolf FJ (1960) Plasma cholesterol lowering action of bile acid binding polymers in experimental animals. J Lipid Res 1:469–473

    CAS  PubMed  Google Scholar 

  • Toda H, Kihara K, Hashimoto M, Mizogami S (1988) Bile acid binding and hypocholesterolemic activity of a new anion exchange resin from 2-methylimidazol and epichlorhydrin. J Pharm Sci 77:531–533

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Boucher .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Boucher, P., Vogel, H.G. (2015). Interruption of Bile Acid Recirculation. In: Hock, F. (eds) Drug Discovery and Evaluation: Pharmacological Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27728-3_50-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27728-3_50-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27728-3

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics